Molecular mechanisms driving oncogenesis in KRAS mutant non-small cell lung cancer

被引：0
|
作者：
Holderfield, Matthew
McCormick, Frank
Nagel, Tobi
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-5752
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5752
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Molecular Characterization and Prognosis of Patients with KRAS Mutant Non-small Cell Lung Cancer
    Gutierrez Sainz, L.
    Villamayor, J.
    Higuera, O.
    Cruz Castellanos, P.
    Vinal Lozano, D.
    Esteban Rodriguez, I.
    Regojo, R. M.
    Pelaez Garcia, A.
    Heredia Soto, V.
    Mendiola, M.
    Rosas Alonso, R.
    Rodriguez Antolin, C.
    Ibanez de Caceres, I.
    de Castro Carpeno, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S620 - S621
  • [2] Is CRAF required for the maintenance of KRAS mutant non-small cell lung cancer?
    Russell, P.
    Wickenden, J.
    Cadwallader, K.
    Maguire, S.
    Joel, J.
    Stockdale, M.
    Chicas, A.
    Banka, D.
    Darman, R.
    Perino, S.
    Fekkes, P.
    Smith, P.
    Zhu, P.
    Buonamici, S.
    Moore, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 171 - 171
  • [3] KRAS in non-small cell lung cancer
    Amanam, I.
    Gupta, R.
    Mambetsariev, I.
    Koczywas, M.
    Cristea, M.
    Massarelli, E.
    Reckamp, K. L.
    Salgia, R.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [4] The role of EphA2 in KRAS mutant non-small cell lung cancer
    Amato, Katherine
    Wang, Shan
    Hastings, Andrew
    Chen, Haiying
    Colvin, Daniel
    Ye, Fei
    Chen, Jin
    [J]. MOLECULAR CANCER RESEARCH, 2014, 12
  • [5] Evaluating Racial Differences in KRAS-Mutant Non-Small Cell Lung Cancer
    Aredo, J.
    Padda, S.
    Kunder, C.
    Han, S.
    Wakelee, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1133 - S1133
  • [6] KRAS-Mutant non-small cell lung cancer: From biology to therapy
    Ferrer, Irene
    Zugazagoitia, Jon
    Herbertz, Stephan
    John, William
    Paz-Ares, Luis
    Schmid-Bindert, Gerald
    [J]. LUNG CANCER, 2018, 124 : 53 - 64
  • [7] A role of nicotinamide phosphoribosyltransferase in growth of KRAS mutant non-small cell lung cancer
    Okumura, Shunsuke
    Sasaki, Takaaki
    Ohsaki, Yoshinobu
    [J]. CANCER RESEARCH, 2015, 75
  • [8] Mutant KRAS decouples glycolysis from cell mechanics in non-small cell lung cancer
    Park, Jin Suk
    Sudderth, Jessica
    Gao, Boning
    Bachoo, Robert
    Danuser, Gaudenz
    [J]. CANCER RESEARCH, 2017, 77
  • [9] Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities
    Zhang, Jun
    Park, Dongkyoo
    Shin, Dong M.
    Deng, Xingming
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (01) : 11 - 16
  • [10] Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis
    Fariborz Mortazavi
    Jie Lu
    Ryan Phan
    Michael Lewis
    Kenny Trinidad
    Amir Aljilani
    Gholamhossein Pezeshkpour
    Fuyuhiko Tamanoi
    [J]. BMC Cancer, 15
12345